Description
Amplicon-seq™ enables high-sensitivity confirmation of on- and off-target mutations in edited cell lines and tissues of interest. Targeted amplicon sequencing is guided by data from nomination assays (ONE-seq, GUIDE-seq™, etc.), enabling precise validation of gene-editing outcomes. By delivering detailed and accurate editing confirmation, Amplicon-seq supports regulatory expectations, reduces the risk of regulatory filing delays, and can strengthen the safety profile of your cell and gene therapy development programs.